Global Scans · Genetics · Weekly Summary

• [New] The ARTEMIS and AQUARIUS studies will evaluate the intravitreal gene therapy for neovascular AMD, after earlier trials demonstrated durable treatment effects. PentaVision
• [New] Millions of women with breast cancer could be spared chemotherapy with a groundbreaking genomic test, according to the results of one trial that could transform guidelines worldwide. The Guardian
• [New] Many people with breast cancer can safely avoid chemotherapy with the use of a gene test, potentially sparing them unnecessary side effects without increasing the risk of the cancer returning, a large international clinical trial led by UCL has found. News-Medical
• [New] Researchers at Penn State College of Medicine have identified an unexpected DNA repair gene that could help expand the use of targeted therapies currently reserved for patients with BRCA-mutant cancers. SciTechDaily
• [New] The Race: The defining security dynamic of late 2026 will not just be AI finding bugs, but the race between AI-accelerated exploit development and AI-accelerated automated patching generation, or AI-assisted exploitation signature creation. FIRST - Forum of Incident Response and Security Teams
• [New] Generative AI is transforming the workplace faster than ever, but new research from the University of Vaasa suggests the biggest threat may not be AI itself - it's falling behind in learning how to use it. ScienceDaily
• [New] The convergence of AI-generated content risks, rising patient expectations, and the digital health market's explosive growth makes 2026 the defining year for healthcare organizations to establish their content authority. TopDoctor Magazine
• [New] Social media health influencers and TikTok doctors generate high engagement but low clinical credibility, creating positioning risks for healthcare organizations. TopDoctor Magazine
• [New] AI investments could generate value equivalent to as much as 11% of revenue across functional areas for biopharma, and up to 12% in cost savings for some medtech players over a two-to-three-year horizon. Pharmaceutical Commerce
• [New] Over the last decade, the use of generics has saved billions of dollars every year, and it is expected that biosimilars will soon prove to be a cost-effective alternative and can play an important role in driving down healthcare costs globally. PubMed Central (PMC)
• [New] Energy constraints on Earth will increasingly limit the growth of artificial intelligence, making space-based power generation and computing capacity an attractive long-term solution. The WealthAdvisor
• [New] The first-in-human clinical trial of a new investigational genetic therapy that aims to lower cholesterol in people at increased risk of cardiovascular disease will take place at the Victorian Heart Hospital and the Victorian Heart Institute. Pulse+IT
• [New] The most recent 2026 ODNI Annual Threat Assessment warned, Beijing is investing heavily in collecting health and genetic data at scale as AI and advanced technologies help build weapons design for battlefield advantage. RCHealth
• [New] Genomics Technology is expected to account for 42.1% of the technology segment in 2026. FactMr
• [New] Therapeutics is anticipated to account for 47.3% of the product segment in 2026, while Genomics Technology is expected to remain the leading application with around 42.1% share. FactMr
• [New] If technological progress continues apace, digital genebanks might be ready in the 2030s. PubMed Central (PMC)
• [New] The next generation of BCI systems will not merely read neural signals but write them with sufficient precision to create artificial sensory experiences indistinguishable from natural perception. Neuroba
• [New] Wheat yields fall by more than 5% for every degree of warming - a quiet threat to the food security that India spent generations building. The New Indian Express
• [New] Societies will need to rethink how land, water, energy, and raw materials are used if future generations are to live safely and sustainably. ScienceDaily
• [New] A shock government-backed report this week warned of the danger of a lost generation of young people in Britain, as the number of 16 - to 24-year-olds not in education, employment or training rose to more than 1 million. The Guardian
• [New] Continued public and private support for early-stage development will remain important to ensure that Singapore sustains a robust pipeline of start-ups capable of scaling into the next generation of growth-stage companies. ST
• [New] With dairy prices rising again and consumption declining in Iran, experts have warned about the spread of anaemia, osteoporosis, malnutrition, and short stature in future generations. NCRI

Last updated: 14 June 2026